Expression of neurotrophins receptor p75NTR in human breast cancer resistant cell line and its correlation with multidrug resistance
10.3969/j.issn.1006-5725.2017.09.007
- VernacularTitle:神经营养因子受体p75NTR在乳腺癌耐药细胞中的表达及其与多药耐药的相关性
- Author:
Xiaofang DENG
;
Gang XU
;
Lizhen HE
- Keywords:
Breast cancer;
Neurotrophins receptor p75/p75NTR;
Multidrug resistance
- From:
The Journal of Practical Medicine
2017;33(9):1389-1393
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of neurotrophins receptor 75NTR in human breast cancer resistant cell line and its correlation with multidrug resistance. Methods Western blot was used to detect the expression level of p75NTR protein in various breast cancer cell lines and multidrug resistant cell lines. The over-expression vector and siRNA vector of p75NTR were constructed by gene recombination method. Western blot was used to detect the expression levels of p75NTR protein in transfected p75NTR and p75NTR - siRNA breast cancer resistant cell line MDA-MB-231/ADR;the sensitivity of MDA-MB-231 and MDA-MB-231/ADR to different chemotherapeutic anticancer drug (PTX ,ADM ,GEM ,DDP ,OXA) and the multi-drug resistance effects in over-expression and knock-down p75NTR MDA-MB-231/ADR were detected by CCK-8 assay. Results Western blot result showed that the expressions of p75NTR protein in the multidrug-resistant breast cancer cell lines MDA-MB-231/ADR and MCF-7/5-FU were higher than that of other breast cancer cell lines. Over-expression of p75NTRcan up-regulate the expression of p75NTR protein in MDA-MB-231/ADR;the CCK-8 assay indicated that over-expression of p75NTR can effectively enhance the resistance of MDA-MB-231/ADR cells to ADM,GEM and OXA. Conclusion The expression of p75NTR in breast cancer resistant cell line is higher than that of its parental cell line;over-expression of p75NTR can reduce the sensitivity to chemotherapeutic drugs and promote its multidrug resistance.
